Alira Health Adds CMC Services through Acquisition of Chamow & Associates

Chamow & Associates’ expertise in biopharmaceutical product development expands Alira Health’s lifecycle of healthcare advisory services.   

News
Published on:
January 7, 2021

FRAMINGHAM, Mass. – January 7, 2021 – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announced it has acquired Chamow & Associates, a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality assurance, and regulatory compliance to Alira Health’s Product Development and Regulatory practices, which now offer a full range of services, from discovery to approval, across the U.S. and EU. Chamow & Associates’ Team of Senior Advisors complement Alira Health’s existing offerings with expertise to help clients overcome CMC challenges throughout the development process.

“Our mission at Alira Health to enable healthcare transformation and support clients in the earliest stages of development, is critical to efficiently and safely shepherd innovations into the hands of patients,” said Gabriele Brambilla, Chief Executive Officer at Alira Health. Steven Chamow has built a powerful combination of CMC capabilities, technical proficiency, and biologic expertise into his firm. We are proud to welcome them to the Alira Health family, and to offer preclinical and clinical-stage biotechnology companies a lifecycle of solutions to help bring new therapies to patients.”

Gabriele Brambilla

“We are excited and honored to become part of the Alira Health network, and to join a talented team of experts with a complementary mission,” said Dr. Steven Chamow, President of Chamow & Associates. “Becoming part of the Alira Health family will allow Chamow & Associates to further build our team and greatly expand our work with clients. By adding CMC expertise and advisory to Alira Health’s suite of services, we have a tremendous opportunity to provide comprehensive support to meet the needs of pharmaceutical companies at any stage of the development process.”

 

Steven Chamow will become Alira Health’s Senior Vice President, CMC Development and will lead biopharmaceutical product development.
Lighthouse BioPartners acted as a financial advisor to Chamow & Associates for this transaction.

About Chamow & Associates:
Chamow & Associates is a leading biopharmaceutical consulting company based in the San Francisco Bay Area. Since 2008, the company has provided integrated CMC services, including molecular engineering, process development and manufacturing, quality, regulatory, and project management services, to clinical-stage biotechnology companies around the world. Chamow & Associates focuses on monoclonal antibodies and derivatives, including bispecific antibodies and antibody drug conjugates, in addition to other recombinant protein products.

Read the press release on BusinessWire here.

Related news

Regulatory
News February 2, 2021
We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System
We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.
Advanced Analytics Regulatory Research & Development
News November 20, 2020
Alira Health’s Ventures Portfolio Company, X-COR Therapeutics, Closes Initial $2.6M Funding Round
Alira Health congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.(...)
Regulatory
Publications November 1, 2020
Reduce Time to Market with Pre-IND Meetings
Did you know reducing time to market is one of the biggest challenges companies face when seeking FDA approval on their drug development plans and clinical trials?
Clinical
Publications September 4, 2020
Clinical Trial Management – The Dharmic Approach
In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance (and certified yoga instructor), writes about the connections between yoga, dharma, and(...)
MedTech Regulatory
Publications August 11, 2020
CMS Issues Proposed Rule to Cover ‘Breakthrough’ Medical Devices
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive(...)
Pharma Regulatory
News July 9, 2020
We Welcome Olga Carroll, PhD as Vice President, Global Regulatory Affairs
We are pleased to announce that Olga Carroll, Ph.D. joined the firm as Vice President of Regulatory.
Clinical
Publications July 1, 2020
Clinical Trials Trends: Remote Monitoring
The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the concept of remote monitoring existed before the pandemic, with(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.